Trial Profile
Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular Carcinoma
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Pharmacodynamics; Pharmacogenomic; Therapeutic Use
- 14 Apr 2016 New trial record